IRF5 and metabolic dysfunction-associated steatohepatitis: Additionally, it was shown that mice lacking IRF5 in myeloid cells demonstrated reduced hepatic fibrosis in the acute CCl4 toxic model and in the nonalcoholic steatosis model (NASH).